[Transfusion-associated graft-versus-host disease and its prevention]

A novel splice-site mutation in the AAGAB gene segregates with hereditary punctate palmoplantar keratoderma and congenital dysplasia of the hip in a large family.

Clinical and experimental dermatology·2013

Met-induced membrane blebbing leads to amoeboid cell motility and invasion.

Oncogene·2013

Non-syndromic autosomal recessive congenital ichthyosis in the Israeli population.

Clinical and experimental dermatology·2013

Beneficial effect of acitretin in Chanarin-Dorfman syndrome.

Clinical and experimental dermatology·2011

Ewing Sarcoma tumor cells express CD34: implications for autologous stem cell transplantation.

Bone marrow transplantation·2007

Tumor cells are present in stem cell harvests of Ewings sarcoma patients and their persistence following transplantation is associated with relapse.

Pediatric blood & cancer·2004

[Oculoplastics and Orbital Surgery Section: Orbital Fractures].

Harefuah·2026

[Atypical Presentation of Extensive Aortic Dissection: Lessons from a Silent Killer].

Harefuah·2026

[Eyeball or Eye Wheel?]

Harefuah·2026

[Emerging Trends in Pediatric rheumatology: Key Insights from the PReS 2025 European Congress - Helsinki, Finland, September 2025].

Harefuah·2026

[The Laterality of Endometriosis].

Harefuah·2026

[OASIS: Long-Term Implications on Women's Quality of Life].

Harefuah·2026

Blinatumomab administration in the outpatient setting: Safety and health care utilization.

Cancer·2026

Subcutaneous versus intravenous ultra-low dose rituximab in rheumatoid arthritis: a randomised controlled PK-PD non-inferiority trial.

Rheumatology (Oxford, England)·2026

The Role of γδ T Cells in Ischemic Stroke: Insights From the Perspective of the Brain-Gut Axis.

CNS neuroscience & therapeutics·2026

Macrophage migration inhibitory factor promotes immune evasion in multiple myeloma through myeloid-derived suppressor cell immunosuppression and major histocompatibility complex class I downregulation: implications for targeted therapy.

Haematologica·2026

Janus kinase inhibitors as an evolving treatment for lymphomas and immune-mediated complications.

Haematologica·2026

Brentuximab vedotin as consolidation treatment in patients with stage I/II Hodgkin's lymphoma and FDG-PET positivity after 2 cycles of ABVD: final analysis of the BRAPP2 trial.

Haematologica·2026

Related Experiment Videos

[Transfusion-associated graft-versus-host disease and its prevention]

Related Concept Videos

A novel splice-site mutation in the AAGAB gene segregates with hereditary punctate palmoplantar keratoderma and congenital dysplasia of the hip in a large family.

Met-induced membrane blebbing leads to amoeboid cell motility and invasion.

Non-syndromic autosomal recessive congenital ichthyosis in the Israeli population.

Beneficial effect of acitretin in Chanarin-Dorfman syndrome.

Ewing Sarcoma tumor cells express CD34: implications for autologous stem cell transplantation.

Tumor cells are present in stem cell harvests of Ewings sarcoma patients and their persistence following transplantation is associated with relapse.

[Oculoplastics and Orbital Surgery Section: Orbital Fractures].

[Atypical Presentation of Extensive Aortic Dissection: Lessons from a Silent Killer].

[Eyeball or Eye Wheel?]

[Emerging Trends in Pediatric rheumatology: Key Insights from the PReS 2025 European Congress - Helsinki, Finland, September 2025].

[The Laterality of Endometriosis].

[OASIS: Long-Term Implications on Women's Quality of Life].

Blinatumomab administration in the outpatient setting: Safety and health care utilization.

Subcutaneous versus intravenous ultra-low dose rituximab in rheumatoid arthritis: a randomised controlled PK-PD non-inferiority trial.

The Role of γδ T Cells in Ischemic Stroke: Insights From the Perspective of the Brain-Gut Axis.

Macrophage migration inhibitory factor promotes immune evasion in multiple myeloma through myeloid-derived suppressor cell immunosuppression and major histocompatibility complex class I downregulation: implications for targeted therapy.

Janus kinase inhibitors as an evolving treatment for lymphomas and immune-mediated complications.

Brentuximab vedotin as consolidation treatment in patients with stage I/II Hodgkin's lymphoma and FDG-PET positivity after 2 cycles of ABVD: final analysis of the BRAPP2 trial.

Related Experiment Videos

[Transfusion-associated graft-versus-host disease and its prevention]

Related Concept Videos

Related Articles